NTRA News and Press, Natera Inc. From 03/10/21

Natera (NTRA) announces that the first patient has been screened in a new phase III trial that uses its tumor-informed, personalized molecular residual disease ((MRD)) test, Signatera, as a companion diagnostic to identify muscle-invasive urothelial carcinoma ((MIUC)) patients eligible f...

Natera and Genentech Initiate Phase III Trial Using Signatera™ as a Companion Diagnostic for Atezolizumab in Early-Stage Muscle-Invasive Bladder Cancer Signatera used to identify muscle-invasive urothelial carcinoma patients who are MRD-positive after surgery, for enrollm...

Natera, Inc. (NTRA) Q4 2020 Earnings Conference Call February 25, 2021 04:30 PM ET Company Participants Michael Brophy - Chief Financial Officer Steve Chapman - Chief Executive Officer Matt Rabinowitz - Co-Founder & Chairman Solomon Moshkevich - General Manager of Oncology Conference Call...

The following slide deck was published by Natera, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: Natera, Inc. 2020 Q4 - Results - Earnings Call Presentation

Gainers: [[GRPN]] +12.8%. [[IHRT]] +10.2%. [[ACIW]] +10.1%. [[NTRA]] +8.5%. [[ETSY]] +4%.Losers: [[TCDA]] -23.1%. [[MRIN]] -12.9%. [[TPIC]] -10%. [[TUSK]] -9.6%. [[GNMK]] -9.6%. For further details see: ETSY, GRPN, TPIC and GNMK among after-hours movers

Natera (NTRA): Q4 GAAP EPS of -$0.89 misses by $0.27.Revenue of $112.4M (+35.1% Y/Y) beats by $5.77M.Natera anticipates 2021 total revenue of $500 million to $525 million; 2021 cost of revenues to be approximately 47% to 52% of revenues; selling, general and administrative costs to be approxi...

Natera Reports Fourth Quarter and Year 2020 Financial Results PR Newswire SAN CARLOS, Calif., Feb. 25, 2021 /PRNewswire/ — Natera, Inc. (NASDAQ:  NTRA), a pioneer and global leader in cell-free DNA testing, today reported financial results for the fo...

Natera to Participate in the Cowen 41st Annual Health Care Conference PR Newswire SAN CARLOS, Calif. , Feb. 23, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will webcast a ...

Natera Announces Fourth Quarter and Fiscal 2020 Earnings Conference Call PR Newswire SAN CARLOS, Calif. , Feb. 18, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, and Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA testing, today announced that the two companies have entered into a partnership in the field of personalized oncology. The partnership will pair P...